IRIS Accounts Production v26.1.0.640 SC808652 Board of Directors Board of Directors 29.4.24 30.4.25 30.4.25 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC8086522024-04-28SC8086522025-04-30SC8086522024-04-292025-04-30SC8086522024-04-28SC808652ns15:Scotland2024-04-292025-04-30SC808652ns14:PoundSterling2024-04-292025-04-30SC808652ns10:Director12024-04-292025-04-30SC808652ns10:Director22024-04-292025-04-30SC808652ns10:PrivateLimitedCompanyLtd2024-04-292025-04-30SC808652ns10:SmallEntities2024-04-292025-04-30SC808652ns10:AuditExempt-NoAccountantsReport2024-04-292025-04-30SC808652ns10:SmallCompaniesRegimeForDirectorsReport2024-04-292025-04-30SC808652ns10:SmallCompaniesRegimeForAccounts2024-04-292025-04-30SC808652ns10:FullAccounts2024-04-292025-04-30SC80865212024-04-292025-04-30SC808652ns10:RegisteredOffice2024-04-292025-04-30SC808652ns5:CurrentFinancialInstruments2025-04-30SC808652ns5:Non-currentFinancialInstruments2025-04-30SC808652ns5:ShareCapital2025-04-30SC808652ns5:RetainedEarningsAccumulatedLosses2025-04-30SC808652ns5:NetGoodwill2024-04-292025-04-30SC808652ns5:IntangibleAssetsOtherThanGoodwill2024-04-292025-04-30SC808652ns5:PlantMachinery2024-04-292025-04-30SC808652ns5:NetGoodwill2025-04-30SC808652ns5:PlantMachinery2025-04-30
REGISTERED NUMBER: SC808652 (Scotland)













UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 29 APRIL 2024 TO 30 APRIL 2025

FOR

IMPLANTSSCOTLAND LTD

IMPLANTSSCOTLAND LTD (REGISTERED NUMBER: SC808652)






CONTENTS OF THE FINANCIAL STATEMENTS
for the period 29 APRIL 2024 TO 30 APRIL 2025




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


IMPLANTSSCOTLAND LTD

COMPANY INFORMATION
for the period 29 APRIL 2024 TO 30 APRIL 2025







DIRECTORS: Dr V Sharda
Dr A A Nohawica-Heer





REGISTERED OFFICE: c/o Thomas Barrie & Co LLP
4th Floor, Atlantic House
1A Cadogan Street
Glasgow
G2 6QE





REGISTERED NUMBER: SC808652 (Scotland)





ACCOUNTANTS: Thomas Barrie & Co LLP
4th Floor, Atlantic House
1a Cadogan Street
Glasgow
G2 6QE

IMPLANTSSCOTLAND LTD (REGISTERED NUMBER: SC808652)

STATEMENT OF FINANCIAL POSITION
30 APRIL 2025

Notes £   
FIXED ASSETS
Intangible assets 4 88,918
Tangible assets 5 51,010
139,928

CURRENT ASSETS
Stocks 500
Debtors 6 47,581
Cash at bank and in hand 25,014
73,095
CREDITORS
Amounts falling due within one year 7 (34,246 )
NET CURRENT ASSETS 38,849
TOTAL ASSETS LESS CURRENT
LIABILITIES

178,777

CREDITORS
Amounts falling due after more than one year 8 (212,307 )
NET LIABILITIES (33,530 )

CAPITAL AND RESERVES
Called up share capital 100
Retained earnings (33,630 )
(33,530 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 April 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 April 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

IMPLANTSSCOTLAND LTD (REGISTERED NUMBER: SC808652)

STATEMENT OF FINANCIAL POSITION - continued
30 APRIL 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 11 May 2026 and were signed on its behalf by:




Dr A A Nohawica-Heer - Director



Dr V Sharda - Director


IMPLANTSSCOTLAND LTD (REGISTERED NUMBER: SC808652)

NOTES TO THE FINANCIAL STATEMENTS
for the period 29 APRIL 2024 TO 30 APRIL 2025

1. STATUTORY INFORMATION

Implantsscotland Ltd is a private company, limited by shares, registered in Scotland, registration number SC808652. The registered office is c/o Thomas Barrie & Co Llp 4th Floor, Atlantic House, 1a Cadogan Street, Glasgow, United Kingdom, G2 6QE.

The principal activity of the company is dentistry.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The presentational and functional currency of the financial statements is Pounds Sterling (£).

Significant judgements and estimates
In preparing these financial statements, the directors are required to make judgements, estimates and assumptions that affect the application of the Company's accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to estimates are recognised prospectively.

The following judgements and estimates have had the most significant effects on amounts recognised in the financial statements:

Plant and equipment
The estimates and assumptions made to determine asset lives require judgements to be made as regards useful lives and residual values. The useful lives and residual values of the company's financial assets are determined by management at the time the asset is acquired and reviewed annually for appropriateness. The lives are based on management experience with similar assets. The depreciation rates applied are outlined later in these notes.

Turnover
Turnover is measured at the fair value of consideration received or receivable, taking into account the amount of any discounts and rebates allowed by the entity, but excluding value added tax and other sales taxes.

Dental Services
Income from dental services is recognised when performed.

Management Charges
Management charges relate to the company's allocation of shared dental practice costs, recognised in the period to which they relate.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2024, is being amortised evenly over its estimated useful life of ten years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

IMPLANTSSCOTLAND LTD (REGISTERED NUMBER: SC808652)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the period 29 APRIL 2024 TO 30 APRIL 2025

2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Plant and machinery etc - 10% on cost

The carrying values of tangible fixed assets are reviewed annually for impairment if events or changes in circumstances indicate the carrying values may not be recoverable.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
The company has financial assets and financial liabilities of a kind that qualify as basic financial instruments.

Debtors
Short term debtors are measured at transaction price, less any impairment.

Cash and cash equivalents
Cash and cash equivalents comprise cash balances, including bank overdrafts that are payable on demand and form an integral part of the company's cash management.

Creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Provisions
Provisions are determined by discounting the expected future cash flows at a pre-tax rate that reflects current market assessments of the time value of money and the risks specific to the liability. The unwinding of the discount is recognised as finance cost.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

IMPLANTSSCOTLAND LTD (REGISTERED NUMBER: SC808652)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the period 29 APRIL 2024 TO 30 APRIL 2025

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 3 .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
Additions 98,798
At 30 April 2025 98,798
AMORTISATION
Charge for period 9,880
At 30 April 2025 9,880
NET BOOK VALUE
At 30 April 2025 88,918

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
Additions 56,678
At 30 April 2025 56,678
DEPRECIATION
Charge for period 5,668
At 30 April 2025 5,668
NET BOOK VALUE
At 30 April 2025 51,010

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Amounts owed by associates 47,581

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Bank loans and overdrafts 26,934
Hire purchase contracts 1,356
Taxation and social security 2,339
Other creditors 3,617
34,246

IMPLANTSSCOTLAND LTD (REGISTERED NUMBER: SC808652)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the period 29 APRIL 2024 TO 30 APRIL 2025

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
£   
Bank loans 207,111
Hire purchase contracts 5,196
212,307

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 99,375

9. RELATED PARTY DISCLOSURES

During the year, a loan totalling £47,581 was received from Vikania Ltd, a company that has directors and shareholders in common.

This loan is interest fee and has no fixed terms of repayment.